T2	KeyEntity 161 184;200 204	Tripeptidyl-peptidase I CLN2
T3	Entity 235 274	sedolisins (serine-carboxyl peptidases)
T5	Entity 334 365	fatal neurodegenerative disease
T6	Entity 377 422	late-infantile neuronal ceroid lipofuscinosis
T7	KeyEntity 682 686	CLN2
T8	Entity 1081 1110	Pseudomonas sp. 101 sedolisin
T9	Entity 999 1036	three-dimensional model of human CLN2
R3	participates_in Arg1:T8 Arg2:T9	
T10	KeyEntity 1125 1129	CLN2
T11	Entity 1138 1154	highly conserved
T12	Entity 1159 1177	widely distributed
T13	Entity 1380 1392	CLN2 enzymes
T14	Entity 1336 1363	almost completely conserved
T15	Entity 1434 1446	tripeptidase
T16	Entity 1649 1668	specific inhibitors
R4	participates_in Arg1:T10 Arg2:T11	
R5	participates_in Arg1:T10 Arg2:T12	
R6	participates_in Arg1:T13 Arg2:T14	
T17	KeyEntity 11 41	tripeptidyl-peptidase I (CLN2)
T18	Entity 45 55	ubiquitous
T19	Entity 60 76	highly conserved
T20	KeyEntity 91 107	sedolisin family
T21	KeyEntity 111 137	serine-carboxyl peptidases
T1	Entity 463 480	genomic sequences
T4	Entity 727 745	eukaryotic species
T22	Entity 783 795	80% identity
T23	Entity 830 837	macaque
T24	Entity 839 844	mouse
T25	Entity 846 849	rat
T26	Entity 851 854	dog
T27	Entity 860 863	cow
T28	Entity 932 953	fish (fugu and zebra)
T29	Entity 969 995	frogs (Xenopus tropicalis)
T30	KeyEntity 1717 1748	tripeptidyl-peptidase I (TPP-I)
T31	KeyEntity 1940 1945	TPP-I
T32	KeyEntity 2006 2010	CLN2
T33	KeyEntity 2104 2108	CLN2
T34	Entity 2063 2074;2082 2100	abolishment enzymatic activity
R2	participates_in Arg1:T34 Arg2:T33	
T35	Entity 2136 2177	fatal inherited neurodegenerative disease
T36	Entity 2179 2234	classical late-infantile neuronal ceroid lipofuscinosis
R7	is_subclass_of Arg1:T36 Arg2:T35	
R8	participates_in Arg1:T36 Arg2:T34	
T37	KeyEntity 2305 2309	CLN2
T38	Entity 2315 2331	serine peptidase
T39	KeyEntity 2454 2458	CLN2
T40	Entity 2536 2570	high-resolution crystal structures
#2	AnnotatorNotes T40	experimental_procedure
T41	KeyEntity 2634 2638	CLN2
T42	Entity 2640 2649	sedolisin
T43	Entity 2654 2665	kumamolisin
R9	participates_in Arg1:T42 Arg2:T40	
R10	participates_in Arg1:T43 Arg2:T40	
T44	Entity 2768 2794	serine-carboxyl peptidases
T45	Entity 2842 2889	fully conserved catalytic triad (Ser, Glu, Asp)
R11	is_part_of Arg1:T45 Arg2:T44	
T46	Entity 2916 2919	Asp
T47	Entity 2927 2940	oxyanion hole
R12	is_part_of Arg1:T46 Arg2:T47	
T48	Entity 2946 2955	Sedolisin
T49	Entity 2988 3034	kumamolisin, aorsin [9], and physarolisin [10]
T50	Entity 3059 3066	archaea
T51	Entity 3068 3076	bacteria
T52	Entity 3078 3083	fungi
T53	Entity 3088 3095	amoebae
T54	KeyEntity 3159 3163	CLN2
T55	Entity 3195 3205	sedolisins
R13	is_subclass_of Arg1:T2 Arg2:T3	
T56	Entity 1581 1605	physiological substrates
T57	Entity 1672 1676	CLN2
R14	interacts_with Arg1:T16 Arg2:T57	
T58	Entity 2754 2764	sedolisins
R1	is_part_of Arg1:T45 Arg2:T58	
T59	KeyEntity 3303 3307	CLN2
T60	Entity 3360 3380	genomic distribution
T61	Entity 3453 3468	crystallization
T62	Entity 3541 3556	crystallography
#1	AnnotatorNotes T62	experimental_test
T63	Entity 3560 3563	NMR
#3	AnnotatorNotes T63	experimental_test
T64	Entity 3603 3621	molecular modeling
T65	Entity 3770 3780	inhibitors
T66	Entity 3859 3871	HIV protease
T67	Entity 3902 3911	peptidase
T68	Entity 3919 3930	coronavirus
T69	Entity 3947 3980	severe acute respiratory syndrome
T70	Entity 4034 4061	molecular homology modeling
T71	KeyEntity 4091 4095	CLN2
T72	Entity 4147 4168	biological substrates
T73	Entity 4207 4236	design of specific inhibitors
#4	AnnotatorNotes T70	experimental_test
T74	KeyEntity 4291 4308	CLN2-like enzymes
T75	KeyEntity 4348 4352	CLN2
T76	Entity 4379 4389	sedolisins
R15	is_subclass_of Arg1:T75 Arg2:T76	
T77	Entity 4395 4421	highly conserved sequences
T78	Entity 4494 4506	195 residues
T79	Entity 4534 4544	maturation
T80	Entity 4559 4582	active catalytic domain
T81	KeyEntity 4621 4625	CLN2
T82	Entity 4756 4771	563 amino acids
T83	Entity 4786 4810	single polypeptide chain
R16	is_part_of Arg1:T82 Arg2:T83	
T84	Entity 4831 4841	prosegment
T85	Entity 4850 4866	catalytic domain
R17	is_part_of Arg1:T84 Arg2:T83	
R18	is_part_of Arg1:T85 Arg2:T83	
T86	KeyEntity 4890 4900	mouse CLN2
T87	Entity 4912 4927;4935 4945	single deletion prosegment
R19	is_part_of Arg1:T87 Arg2:T86	
T88	Entity 4959 4976;4998 5001	sequence identity 81%
T89	Entity 5015 5025;5029 5032	similarity 92%
T90	Entity 5094 5106	88% identity
T91	Entity 5111 5125	94% similarity
T92	Entity 5063 5068;5079 5086	human enzymes
T93	Entity 5073 5086	mouse enzymes
T94	Entity 5163 5177	78.5% identity
T95	Entity 5206 5227	mouse-human orthologs
T96	Entity 5240 5254	mammalian CLN2
T97	Entity 5271 5294	highly conserved enzyme
R20	is_part_of Arg1:T96 Arg2:T97	
T98	KeyEntity 5341 5358	CLN2-like enzymes
T99	Entity 5307 5327	Sequence comparisons
T100	Entity 5402 5409	enzymes
T101	Entity 5425 5435	prosegment
R21	is_part_of Arg1:T101 Arg2:T100	
T102	Entity 5458 5469	active site
T103	Entity 5566 5578	stability of
T104	Entity 5515 5533	conserved residues
T105	Entity 5625 5643	residues identical
T106	Entity 5717 5726	character
T107	Entity 5753 5778	maturation cleavage point
T108	Entity 5794 5804;5812 5825	N terminus active enzyme
T109	KeyEntity 5887 5904	CLN2-like enzymes
T110	Entity 5923 5927	fugu
T111	Entity 6023 6032	zebrafish
T112	Entity 6224 6242	zebrafish sequence
T113	KeyEntity 6280 6289	fugu CLN2
T114	Entity 6321 6329;6335 6352	deletion single nucleotide
T115	Entity 6391 6430	insertions of repeated nucleotide pairs
T116	Entity 6613 6629	global agreement
T117	Entity 6631 6645	69% identities
T118	Entity 6650 6666	83% similarities
T119	Entity 6690 6703	gene sequence
T120	KeyEntity 6711 6725	zebrafish CLN2
R22	participates_in Arg1:T119 Arg2:T120	
T121	Entity 6759 6777	manual corrections
T122	KeyEntity 6832 6843	fugu enzyme
T123	Entity 6845 6865	Inserted nucleotides
T124	Entity 6927 6946	amino acid sequence
T125	KeyEntity 6954 6970	fugu CLN2 analog
T126	KeyEntity 6984 6997	sedolisin-TPP
R23	is_part_of Arg1:T124 Arg2:T125	
T127	Entity 7055 7074	mammalian orthologs
T128	Entity 7120 7150	translated amino acid sequence
T129	Entity 7167 7176;7191 7198	mammalian enzymes
T130	Entity 7181 7198	zebrafish enzymes
T131	Entity 7209 7223	amino terminus
T132	Entity 7231 7248	propeptide region
T133	Entity 7268 7282	30 amino acids
R24	is_part_of Arg1:T131 Arg2:T132	
R25	is_part_of Arg1:T132 Arg2:T128	
T134	Entity 7417 7429	coding frame
T135	Entity 7454 7464	methionine
T136	Entity 7510 7531	full genomic sequence
T137	Entity 7551 7577	fugu sequencing consortium
T138	Entity 7608 7625	catalytic domains
T139	KeyEntity 7668 7672	CLN2
T140	Entity 7678 7683	human
T141	Entity 7685 7689	fugu
T142	Entity 7695 7704	zebrafish
T143	KeyEntity 7753 7757	CLN2
T144	KeyEntity 7629 7633	CLN2
R26	is_part_of Arg1:T138 Arg2:T144	
T145	Entity 7761 7779	Xenopus tropicalis
R27	is_part_of Arg1:T143 Arg2:T145	
T146	Entity 7812 7819	enzymes
T147	Entity 7877 7897	Active site residues
T148	KeyEntity 7926 7930	CLN2
T149	Entity 8001 8019	Xenopus tropicalis
T150	Entity 8067 8091	sedolisin-TPP (AL594774)
T151	Entity 8105 8117	EST database
T152	Entity 8129 8140;8148 8164	middle part catalytic domain
R28	is_part_of Arg1:T150 Arg2:T152	
T153	Entity 8199 8210	active site
T154	Entity 8225 8235	N terminus
T155	Entity 8254 8262;8276 8281	aspartic acids
T156	Entity 8267 8281	glutamic acids
T157	Entity 8301 8316	catalytic triad
R29	is_part_of Arg1:T155 Arg2:T157	
R30	is_part_of Arg1:T156 Arg2:T157	
T158	Entity 8366 8378	75% identity
T159	Entity 8388 8406	fugu sedolisin-TPP
T160	Entity 8412 8424	69% identity
T161	KeyEntity 8430 8440	human CLN2
T162	Entity 8476 8485;8496 8506	bacterial sedolisins
T163	Entity 8489 8506	fungal sedolisins
T164	Entity 8614 8628	CLN2 subfamily
T165	KeyEntity 8648 8682	highly conserved CLN2-like enzymes
T166	Entity 8719 8731	fish species
T167	Entity 8743 8748	frogs
T168	Entity 8773 8783	peptidases
T169	Entity 8815 8826	vertebrates
T170	Entity 8872 8878	humans
T171	Entity 8887 8891	mice
T172	KeyEntity 8960 8970	human CLN2
T173	KeyEntity 8998 9002	CLN2
T174	Entity 9011 9015;9021 9038	lack crystal structure
T175	Entity 9060 9076	protein modeling
T176	Entity 9127 9141	membrane-bound
T177	Entity 9117 9123	enzyme
R31	participates_in Arg1:T177 Arg2:T176	
T178	Entity 9152 9168	sequence 271–294
T179	Entity 9247 9267	transmembrane anchor
T180	Entity 9338 9368	fully water-soluble sedolisins
T181	KeyEntity 9447 9451	CLN2
T182	Entity 9453 9462	sedolisin
T183	Entity 9468 9479	kumamolisin
T184	Entity 9589 9611	homology-derived model
T185	KeyEntity 9615 9625	human CLN2
R32	other_relation Arg1:T184 Arg2:T185	
#5	AnnotatorNotes R32	model
T186	Entity 9652 9666	homology model
T187	Entity 9690 9710	complex of sedolisin
T188	Entity 9718 9744	covalently-bound inhibitor
T189	Entity 9746 9767	pseudo-iodotyrostatin
R33	interacts_with Arg1:T187 Arg2:T189	
T190	KeyEntity 9840 9850	human CLN2
T191	Entity 9883 9905	aldehyde functionality
T192	Entity 9916 9925	C-termini
R34	participates_in Arg1:T191 Arg2:T192	
T193	Entity 9953 9963;9980 9983	inhibitors Oda
T194	Entity 10022 10043	pseudo-iodotyrostatin
T195	Entity 10057 10066	inhibitor
T196	KeyEntity 10082 10086	CLN2
T197	Entity 10259 10288	pseudo-iodotyrostatin complex
T198	KeyEntity 10297 10301	CLN2
T199	Entity 10307 10319	tripeptidase
R35	is_part_of Arg1:T198 Arg2:T199	
T200	Entity 10335 10344	inhibitor
T201	Entity 10396 10413	tripeptide analog
T202	Entity 10423 10432	sedolisin
R36	interacts_with Arg1:T201 Arg2:T202	
T203	Entity 10445 10463	Sequence alignment
T204	Entity 10467 10476;10491 10498	bacterial enzymes
T205	Entity 10481 10498	mammalian enzymes
T206	Entity 10530 10539	sedolisin
T207	Entity 10541 10552	kumamolisin
T208	Entity 10558 10568	human CLN2
T209	Entity 10680 10696	r.m.s. deviation
T210	Entity 10723 10737	Cα coordinates
T211	KeyEntity 10754 10758	CLN2
T212	Entity 10804 10813	sedolisin
T213	Entity 10888 10897	sedolisin
T214	Entity 10902 10913	kumamolisin
T215	Entity 10934 10940;10952 10960	Cys327 residues
T216	Entity 10945 10960	Cys342 residues
T217	Entity 11020 11034	disulfide bond
T218	Entity 11178 11187;11192 11210	cysteines strictly conserved
T220	Entity 11242 11246	CLN2
R37	is_part_of Arg1:T218 Arg2:T220	
T219	Entity 11317 11337	bacterial sedolisins
T221	Entity 11353 11362	disulfide
T222	KeyEntity 11401 11405	CLN2
R38	is_part_of Arg1:T221 Arg2:T222	
T223	Entity 11478 11500	homology-derived model
T224	KeyEntity 11504 11514	human CLN2
T225	Entity 11538 11546	Cα trace
T226	KeyEntity 11550 11554	CLN2
T227	Entity 11516 11530	Ribbon diagram
T228	Entity 11605 11626;11630 11639	highly conserved core sedolisin
T229	Entity 11605 11626;11644 11655	highly conserved core kumamolisin
T230	Entity 11698 11709;11717 11725	Side chains residues
T231	Entity 11748 11755	mutated
R39	participates_in Arg1:T230 Arg2:T231	
T232	Entity 11798 11843	late-infantile neuronal ceroid lipofuscinosis
R40	is_part_of Arg1:T231 Arg2:T232	
T233	Entity 11863 11877	ball-and-stick
T234	Entity 11899 11924	substrate binding pockets
T235	KeyEntity 11928 11932	CLN2
T236	KeyEntity 11937 11946	sedolisin
T237	KeyEntity 11986 11990	CLN2
T238	Entity 12004 12016	tripeptidase
R41	is_part_of Arg1:T237 Arg2:T238	
T239	Entity 12044 12069	substrate-binding pockets
T240	Entity 12071 12073	S1
T241	Entity 12082 12084	S3
T242	Entity 12175 12177	P3
T243	Entity 12185 12194	inhibitor
R42	is_part_of Arg1:T242 Arg2:T243	
T244	Entity 12307 12316	sedolisin
T245	Entity 12320 12331	kumamolisin
T246	Entity 12337 12347	inhibitors
T247	Entity 12365 12373	tyrosine
T248	Entity 12379 12392	phenylalanine
T249	Entity 12407 12416	S1 pocket
R43	participates_in Arg1:T248 Arg2:T249	
R44	participates_in Arg1:T247 Arg2:T249	
T250	Entity 12443 12458	fully conserved
T251	Entity 12475 12485	sedolisins
T252	Entity 12525 12540;12548 12554	right-hand side pocket
T253	Entity 12601 12611	main chain
T254	Entity 12622 12638	residues 164–165
T255	KeyEntity 12719 12729	human CLN2
T256	Entity 12749 12759	main chain
T257	Entity 12787 12814	hydrogen-bonded interaction
T258	Entity 12824 12834;12838 12844	side chain Thr279
R45	interacts_with Arg1:T257 Arg2:T256	
R46	is_part_of Arg1:T258 Arg2:T257	
T259	Entity 12858 12883	signature sequence SGTSAS
T260	Entity 12900 12916	catalytic Ser280
T261	Entity 12959 12965	Asp165
T262	Entity 12981 12990	conserved
T263	Entity 13023 13029;13037 13050	lining oxyanion hole
T264	Entity 13102 13111	S1 pocket
T265	Entity 13139 13150	side chains
T266	Entity 13237 13251	steric barrier
T267	Entity 13256 13273	excluding solvent
T268	Entity 13334 13350	residues 130–132
T269	Entity 13320 13330	main chain
T270	Entity 13366 13382	conserved Gly131
T271	Entity 13466 13476	P1 residue
T272	Entity 13484 13493	substrate
R47	is_part_of Arg1:T271 Arg2:T272	
R48	is_part_of Arg1:T269 Arg2:T268	
T273	Entity 12172 12174	P1
R49	is_part_of Arg1:T273 Arg2:T243	
R50	participates_in Arg1:T261 Arg2:T263	
T274	KeyEntity 13536 13546	human CLN2
T275	Entity 13584 13605	pseudo-iodotyrostatin
T276	Entity 13614 13623;13631 13647;13651 13661	inhibitor sedolisin family peptidases
R51	is_part_of Arg1:T254 Arg2:T253	
R52	is_part_of Arg1:T253 Arg2:T252	
R53	is_subclass_of Arg1:T240 Arg2:T239	
R54	is_subclass_of Arg1:T241 Arg2:T239	
R55	is_part_of Arg1:T247 Arg2:T244	
R56	is_part_of Arg1:T248 Arg2:T244	
R57	is_part_of Arg1:T247 Arg2:T245	
R58	is_part_of Arg1:T248 Arg2:T245	
T277	Entity 13780 13791;13799 13808	stick model inhibitor
T278	Entity 13833 13835;13839 13847	P1 residues
T279	Entity 13836 13847	P3 residues
T280	Entity 13963 13972	sedolisin
T281	Entity 13977 13988	kumamolisin
T282	Entity 14142 14148	Asp179
T283	Entity 14152 14163	kumamolisin
T284	Entity 14095 14101;14109 14115	bottom pocket
T285	Entity 14183 14189	Ser190
T286	Entity 14193 14202	sedolisin
R59	is_part_of Arg1:T285 Arg2:T286	
R60	is_part_of Arg1:T282 Arg2:T283	
T287	Entity 14208 14222	hydrogen bonds
T288	Entity 14230 14241;14249 14258	P1 tyrosine inhibitor
R61	interacts_with Arg1:T282 Arg2:T288	
R62	interacts_with Arg1:T285 Arg2:T288	
T289	KeyEntity 14299 14303	CLN2
T290	Entity 14307 14313	Thr182
T291	Entity 14403 14416	hydrogen bond
T292	Entity 14422 14433	P1 tyrosine
T293	Entity 14476 14482	Glu175
T294	Entity 14486 14495	sedolisin
R63	is_part_of Arg1:T293 Arg2:T294	
T295	Entity 14518 14524	Asp169
T296	Entity 14528 14539	kumamolisin
R64	is_part_of Arg1:T295 Arg2:T296	
T297	KeyEntity 14576 14580	CLN2
T298	Entity 14584 14590	Cys170
R65	is_part_of Arg1:T298 Arg2:T297	
R66	interacts_with Arg1:T290 Arg2:T291	
#6	AnnotatorNotes R66	negative
R67	interacts_with Arg1:T291 Arg2:T292	
T299	Entity 14692 14698	Glu175
T300	Entity 14703 14709	Glu171
T301	Entity 14713 14722	sedolisin
T302	Entity 14666 14683	polar interaction
R68	is_part_of Arg1:T299 Arg2:T301	
R69	is_part_of Arg1:T300 Arg2:T301	
T303	KeyEntity 14770 14774	CLN2
T304	Entity 14778 14784	Ser166
R70	is_part_of Arg1:T304 Arg2:T303	
T305	Entity 14823 14827;14835 14844	side S1 pocket
T306	Entity 14896 14902	Arg179
T307	Entity 14882 14892	side chain
T308	Entity 14906 14915	sedolisin
R71	is_part_of Arg1:T306 Arg2:T308	
R72	is_part_of Arg1:T307 Arg2:T306	
T309	Entity 14945 14951	Ser174
T310	KeyEntity 14955 14959	CLN2
R73	is_part_of Arg1:T309 Arg2:T310	
T311	Entity 15045 15055;15063 15070	main chain protein
T312	Entity 15094 15103	substrate
T313	Entity 15115 15133	not well conserved
T314	Entity 15158 15169	kumamolisin
T315	Entity 15199 15207;15215 15246	deletion corresponding sequence position
R74	participates_in Arg1:T315 Arg2:T314	
T316	Entity 15264 15273	S1 pocket
T317	KeyEntity 15277 15281	CLN2
R75	is_part_of Arg1:T316 Arg2:T317	
T318	Entity 15286 15306	less polar character
R76	is_part_of Arg1:T318 Arg2:T317	
T319	Entity 15374 15394	direct polar anchors
R77	is_part_of Arg1:T319 Arg2:T317	
T320	Entity 15460 15469	S2 pocket
T321	KeyEntity 15473 15477	CLN2
R78	is_part_of Arg1:T320 Arg2:T321	
T322	Entity 15515 15522	solvent
R79	interacts_with Arg1:T322 Arg2:T321	
T323	Entity 15587 15596	sedolisin
T324	Entity 15600 15611	kumamolisin
T325	Entity 15640 15645	Trp81
T326	Entity 15664 15670	Trp129
R80	is_part_of Arg1:T325 Arg2:T323	
R81	is_part_of Arg1:T326 Arg2:T324	
T327	Entity 15803 15809	Tyr130
T328	KeyEntity 15850 15854	CLN2
R82	is_part_of Arg1:T327 Arg2:T328	
T329	Entity 15905 15915;15923 15932	P2 residue substrate
R83	interacts_with Arg1:T327 Arg2:T329	
#7	AnnotatorNotes R83	negative
T330	KeyEntity 16063 16067	CLN2
T331	Entity 16111 16120	S3 pocket
T332	Entity 16144 16165;16174 16180	tripeptidase activity enzyme
T333	Entity 16202 16215;16223 16232	P3 side chain substrate
T334	Entity 16321 16337	N-terminal amine
R84	interacts_with Arg1:T333 Arg2:T334	
T335	Entity 16348 16374	negatively charged residue
T336	KeyEntity 16378 16382	CLN2
T337	Entity 16417 16423	Asp132
R86	is_part_of Arg1:T337 Arg2:T336	
T338	Entity 16480 16491	carboxylate
T339	Entity 16500 16508;16516 16526	nitrogen N-terminus
T340	Entity 16605 16627	hydrogen-bonding range
T341	Entity 16659 16673;16681 16688	torsion angles protein
R85	interacts_with Arg1:T338 Arg2:T339	
T342	Entity 16749 16762	hydrogen bond
T343	Entity 16771 16777	Asp132
T344	Entity 16782 16788	Ser139
R87	interacts_with Arg1:T343 Arg2:T344	
T345	Entity 16874 16880	serine
T346	Entity 16916 16933	CLN2-like enzymes
R88	is_part_of Arg1:T345 Arg2:T346	
T347	Entity 17049 17102	classic late-infantile neuronal ceroid lipofuscinosis
T348	Entity 17199 17215	truncated enzyme
T349	Entity 17232 17251	intron-exon splices
T350	Entity 17292 17323	single amino acid substitutions
T351	Entity 17331 17344	mature enzyme
R89	is_part_of Arg1:T350 Arg2:T351	
T352	Entity 17369 17373	I92N
T353	Entity 17375 17380	E148K
T354	Entity 17382 17387	C170R
T355	Entity 17392 17397	C170Y
T356	Entity 17399 17404	V190D
T357	Entity 17406 17411	G194E
T358	Entity 17413 17418	Q227H
T359	Entity 17420 17425	R252H
T360	Entity 17427 17432	A259E
T361	Entity 17438 17443	S280L
T362	Entity 17536 17552	catalytic serine
T363	KeyEntity 17556 17560	CLN2
R90	is_part_of Arg1:T362 Arg2:T363	
T364	Entity 17603 17621	enzymatic activity
R91	participates_in Arg1:T362 Arg2:T364	
T365	Entity 17715 17721	Val190
T366	Entity 17723 17729	Gly194
T367	Entity 17735 17741	Arg252
T368	Entity 17751 17767	highly conserved
T369	KeyEntity 17780 17784	CLN2
T370	Entity 17803 17813	sedolisins
R92	is_part_of Arg1:T367 Arg2:T369	
R93	is_part_of Arg1:T366 Arg2:T369	
R94	is_part_of Arg1:T365 Arg2:T369	
T371	Entity 17916 17920;17924 17942	loss enzymatic activity
T372	KeyEntity 18076 18080	CLN2
T373	Entity 18059 18072	modifications
R95	participates_in Arg1:T373 Arg2:T372	
T374	Entity 18141 18152;18160 18167	development disease
R96	participates_in Arg1:T373 Arg2:T374	
T375	KeyEntity 18199 18203	CLN2
T376	Entity 18185 18195	inhibitors
T377	Entity 18170 18180	Substrates
R97	is_part_of Arg1:T376 Arg2:T375	
R98	is_part_of Arg1:T377 Arg2:T375	
T378	KeyEntity 18276 18280	CLN2
T379	Entity 18311 18322	truncations
T380	Entity 18327 18348	single-site mutations
T381	KeyEntity 18352 18356	CLN2
R99	is_part_of Arg1:T379 Arg2:T381	
R100	is_part_of Arg1:T380 Arg2:T381	
T382	Entity 18423 18468	late-infantile neuronal ceroid lipofuscinosis
T383	Entity 18517 18529;18536 18560	accumulation autofluorescent material
T384	Entity 18562 18579	ceroid-lipofuscin
T385	Entity 18584 18608	lysosomal storage bodies
T386	Entity 18649 18663	nervous system
R101	participates_in Arg1:T384 Arg2:T385	
R102	is_part_of Arg1:T385 Arg2:T386	
T387	Entity 18725 18734;18738 18764	subunit c mitochondrial ATP synthase
T388	Entity 18814 18831;18839 18847	biological target protease
T389	KeyEntity 18881 18885	CLN2
T390	Entity 18925 18935	N terminus
T391	Entity 18910 18917	subunit
R103	is_part_of Arg1:T391 Arg2:T390	
R104	interacts_with Arg1:T389 Arg2:T391	
T392	KeyEntity 19032 19036	CLN2
T393	Entity 19084 19112	angiotensin-derived peptides
R105	interacts_with Arg1:T392 Arg2:T393	
T394	Entity 19128 19138;19142 19150	efficiency cleavage
T395	Entity 19168 19174;19183 19191	length peptides
T396	Entity 19245 19259	14 amino acids
T397	Entity 19270 19292	tripeptide Asp-Arg-Val
T398	Entity 19310 19320	N terminus
R106	participates_in Arg1:T397 Arg2:T398	
T399	KeyEntity 19335 19339	CLN2
T400	Entity 19398 19404;19412 19434	P side substrate-binding site
T401	Entity 19478 19493;19501 19510	long P' portion substrate
R107	interacts_with Arg1:T399 Arg2:T400	
T402	Entity 19562 19580	peptide acetylated
T403	Entity 19588 19598	N terminus
R108	is_part_of Arg1:T402 Arg2:T403	
T404	Entity 19671 19693	N-terminal amino group
T405	Entity 19717 19723	Asp132
R109	interacts_with Arg1:T404 Arg2:T405	
T406	Entity 19771 19795	tripeptidase specificity
T407	KeyEntity 19799 19803	CLN2
R110	is_part_of Arg1:T406 Arg2:T407	
R111	participates_in Arg1:T405 Arg2:T406	
T408	Entity 19827 19838	tripeptides
T409	Entity 19870 19878	glucagon
R112	is_part_of Arg1:T408 Arg2:T409	
T410	Entity 19951 19962	tripeptides
T411	Entity 19997 20019	substrate-binding site
T412	KeyEntity 20027 20031	CLN2
R113	is_part_of Arg1:T411 Arg2:T412	
R114	participates_in Arg1:T410 Arg2:T411	
T413	Entity 20098 20113	cholecystokinin
T414	Entity 20133 20146	neuropeptides
T415	KeyEntity 20180 20184	CLN2
T416	Entity 20219 20244	collagen-related peptides
R115	interacts_with Arg1:T415 Arg2:T416	
T417	Entity 20255 20266	tripeptides
T418	Entity 20306 20317	Gly-Pro-Met
T419	Entity 20319 20330	Gly-Pro-Arg
T420	Entity 20336 20347	Gly-Pro-Ala
R116	is_subclass_of Arg1:T418 Arg2:T417	
R117	is_subclass_of Arg1:T419 Arg2:T417	
R118	is_subclass_of Arg1:T420 Arg2:T417	
T421	Entity 20384 20395	kumamolisin
T422	Entity 20445 20490	Alicyclobacillus sendaiensis (kumamolisin-As)
T423	Entity 20523 20548	collagen-related peptides
R119	interacts_with Arg1:T421 Arg2:T423	
R120	interacts_with Arg1:T422 Arg2:T423	
T424	Entity 20559 20581	native type I collagen
R121	interacts_with Arg1:T422 Arg2:T424	
R122	interacts_with Arg1:T421 Arg2:T424	
T425	Entity 20597 20619	substrate-binding site
T426	KeyEntity 20623 20627	CLN2
T427	KeyEntity 20780 20784	CLN2
R123	is_part_of Arg1:T425 Arg2:T426	
T428	Entity 20647 20658	kumamolisin
T429	Entity 20669 20678	sedolisin
T430	Entity 20752 20771	collagen-processing
R124	participates_in Arg1:T427 Arg2:T430	
T431	Entity 20846 20865	catalytic machinery
T432	KeyEntity 20869 20873	CLN2
R125	is_part_of Arg1:T431 Arg2:T432	
T433	Entity 20898 20907	sedolisin
T434	Entity 20909 20920	kumamolisin
T435	Entity 20957 20983	serine-carboxyl peptidases
T436	Entity 20989 21008	enzymatic mechanism
T437	Entity 21055 21061;21065 21084	Design inhibitors specific
T438	KeyEntity 21089 21093	CLN2
R126	interacts_with Arg1:T437 Arg2:T438	
T439	Entity 21217 21239	aldehyde functionality
T440	Entity 21258 21279	covalent interactions
T441	Entity 21289 21305	catalytic serine
T442	Entity 21329 21348	chloromethyl ketone
T443	Entity 21447 21457	sedolisins
T444	Entity 21481 21492	tripeptides
T445	Entity 21504 21519;21529 21538	blocking groups N termini
T446	Entity 21544 21571	tripeptide-based inhibitors
T447	Entity 21577 21591	free N termini
R127	is_part_of Arg1:T447 Arg2:T446	
T448	Entity 21671 21689	binding properties
T449	Entity 21755 21772	peptide sequences
T450	KeyEntity 21799 21803	CLN2
R128	interacts_with Arg1:T437 Arg2:T439	
R129	interacts_with Arg1:T437 Arg2:T440	
R130	interacts_with Arg1:T440 Arg2:T441	
R131	interacts_with Arg1:T437 Arg2:T442	
T451	Entity 21834 21844	S1 subsite
T452	Entity 21875 21884	sedolisin
T453	Entity 21888 21899	kumamolisin
T454	Entity 21929 21937	P1 group
R132	is_part_of Arg1:T451 Arg2:T450	
T455	Entity 21992 22022	experimental crystal structure
T456	Entity 22037 22043;22047 22057	design inhibitors
T457	KeyEntity 22114 22118	CLN2
T458	Entity 22153 22170	Homology modeling
T459	KeyEntity 22214 22218	CLN2
T460	Entity 22279 22288;22305 22313	sedolisin proteins
T461	Entity 22293 22313	kumamolisin proteins
T462	Entity 22345 22354;22358 22366	273 pairs Cα atoms
T463	Entity 22467 22509	sedolisin/serine-carboxyl peptidase family
T464	Entity 22671 22680	sedolisin
T465	Entity 22685 22696	kumamolisin
T466	Entity 22645 22653	1GA4.pdb
T467	Entity 22658 22666	1GT9.pdb
R133	other_relation Arg1:T466 Arg2:T464	
#8	AnnotatorNotes R133	database
R134	other_relation Arg1:T467 Arg2:T465	
#9	AnnotatorNotes R134	database
T468	Entity 22811 22827	sedolisin family
T469	Entity 22742 22748;22750 22777	global multiple sequence alignment
T470	Entity 22892 22925	amino acid residue-type variation
T471	Entity 22930 22942	conservation
T472	Entity 22951 22957;22961 22980	family homologous proteins
T473	Entity 23020 23048	pair-wise sequence alignment
R135	is_part_of Arg1:T470 Arg2:T472	
R136	is_part_of Arg1:T471 Arg2:T472	
T474	Entity 23147 23163	GenBank database
#10	AnnotatorNotes T474	database
T475	Entity 23175 23184	sedolisin
T476	Entity 23186 23197	kumamolisin
T477	KeyEntity 23207 23217	human CLN2
T478	Entity 23271 23284	BLAST program
T479	Entity 23310 23329	sequence alignments
T480	Entity 23351 23376	ClustalX computer program
T481	Entity 23424 23449	highly-conserved segments
T482	Entity 23476 23517	crystal structure-identified core regions
T483	Entity 23525 23534;23551 23560	sedolisin sequences
T484	Entity 23539 23560	kumamolisin sequences
R137	is_part_of Arg1:T482 Arg2:T484	
R138	is_part_of Arg1:T482 Arg2:T483	
T485	Entity 23636 23645	sedolisin
T486	Entity 23651 23662	kumamolisin
T487	Entity 23753 23773	structural alignment
T488	Entity 23781 23790;23807 23814	sedolisin protein
T489	Entity 23795 23814	kumamolisin protein
T490	Entity 23898 23923	highly conserved residues
T491	Entity 23931 23943	core regions
R139	is_part_of Arg1:T490 Arg2:T491	
T492	KeyEntity 24031 24041	human CLN2
T493	Entity 24075 24084	sedolisin
T494	Entity 24104 24131	inhibitor pseudo-tyrostatin
T495	Entity 24296 24318	tripeptidase character
T496	KeyEntity 24322 24326	CLN2
R140	is_part_of Arg1:T495 Arg2:T496	
T497	Entity 24491 24516;24524 24537	homology modeling modules Look/GeneMine
T498	Entity 24491 24516;24547 24555	homology modeling modules DeepView
T499	Entity 24393 24411	atomic coordinates
T500	Entity 24596 24600;24624 24631	core protein
T501	Entity 24605 24616;24624 24631	active site protein
T502	Entity 24649 24667	identical residues
T503	Entity 24909 24942	Quanta molecular modeling package
T504	Entity 24980 24989	templates
T505	Entity 25025 25045	surrounding residues
T506	Entity 25100 25110	insertions
T507	Entity 25115 25124	deletions
T508	Entity 25142 25154;25162 25169	loop regions protein
T509	Entity 25208 25216	backbone
T510	Entity 25228 25250	side chain coordinates
T511	Entity 25317 25329;25333 25362	conformation poorly conserved loop regions
T512	Entity 25407 25421	homology model
T513	Entity 24741 24749;24754 24765;24769 24777	position side chains residues
T514	Entity 25494 25505	active site
T515	Entity 25575 25591;25593 25610	highly conserved functional region
T516	Entity 25688 25707	energy minimization
T517	Entity 25708 25716	in vacuo
T518	Entity 25743 25749	CHARMM
T519	Entity 25799 25816	covalent geometry
T520	Entity 25821 25844	non-bonded interactions
T521	Entity 25940 25962	adjusting bond lengths
T522	Entity 25964 25978	3-point angles
T523	Entity 25983 26006	4-point dihedral angles
T524	Entity 26031 26045	atomic overlap
T525	Entity 26058 26070	salt-bridges
T526	Entity 26075 26089	hydrogen bonds
T527	Entity 26111 26137	potential energy functions
T528	Entity 26159 26178	atomic-scale models
T529	Entity 26404 26412	PROCHECK
T530	Entity 26454 26457	PDB
T531	Entity 26464 26483	accession code 1R60
R141	interacts_with Arg1:T494 Arg2:T493	
R142	participates_in Arg1:T503 Arg2:T504	
R143	participates_in Arg1:T503 Arg2:T505	
T532	KeyEntity 26668 26672	CLN2
T533	Entity 26637 26664	three-dimensional structure
T534	Entity 26553 26573	genomic distribution
T535	Entity 26582 26588;26592 26599	family enzymes
T536	Entity 26719 26737;26741 26751	crystal structures sedolisins
T537	Entity 26820 26846	serine-carboxyl peptidases
T538	Entity 26855 26861;26871 26881	design inhibitors
T539	Entity 26904 26933	substrate-enzyme interactions
T540	Entity 26938 26956	enzyme specificity
T541	Entity 27266 27302	Grant-in-Aid for Scientific Research
T542	Entity 27413 27431	NIH grants DK18865
T543	Entity 27413 27422;27436 27443	NIH grant AI39211
T544	Entity 27497 27522	National Cancer Institute
T545	Entity 27524 27553	National Institutes of Health
